BioTime, Inc., a biomedical company, engages in the research and development of synthetic plasma expanders, blood volume substitute solutions, and organ preservation solutions for use in surgery, trauma care, organ transplant procedures, and other areas of medicine. Its lead product, Hextend, is a hetastarch-based synthetic blood plasma volume expander designed to treat hypovolemia in surgery for patients with blood loss.
BTIM at 10:11:20 AM 8/28/2008: 25% Pullback from highs.
